Related Experiment Video
Updated: Feb 18, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Adherence with epinephrine autoinjector prescriptions in primary care
Elissa M Abrams1, Alexander G Singer2, Lisa Lix3
1Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, FE125-685 William Avenue, Winnipeg, MB R3E 0Z2 Canada.
Many epinephrine autoinjector (EA) prescriptions are not filled by patients in Canadian primary care. This highlights a critical gap in anaphylaxis preparedness, emphasizing the need for better patient education on EA importance.
Area of Science:
- Public Health
- Pharmacology
- Anaphylaxis Management
Background:
- Primary adherence to epinephrine autoinjector (EA) prescriptions is crucial for managing anaphylaxis.
- Estimating EA prescription adherence in Canadian primary care settings is essential for public health.
- Understanding adherence rates informs strategies to improve patient access to life-saving medication.
Purpose of the Study:
- To estimate the primary adherence rate for epinephrine autoinjector (EA) prescriptions in Canadian primary care.
- To identify predictors associated with the non-dispensation of new EA prescriptions.
Main Methods:
- Retrospective analysis of electronic medical record and administrative data.
- Definition of primary adherence as EA prescription dispensation within 90 days of being written.
- Utilized multivariable logistic regression to identify predictors of EA prescription filling.
Main Results:
- Only 69.9% of 1212 epinephrine autoinjector (EA) prescriptions were filled between 2012 and 2014.
- A higher number of prescriptions for non-EA medications correlated with an increased likelihood of not filling an EA prescription.
- This study represents the first examination of EA prescription adherence in Canada.
Conclusions:
- A significant rate of non-adherence to epinephrine autoinjector (EA) prescriptions was observed in Canadian primary care.
- The identified non-adherence rate exceeds previously reported figures, suggesting widespread issues with EA prescription fulfillment.
- Consistent patient education on the importance of filling EA prescriptions and maintaining EA availability is recommended for individuals at risk of anaphylaxis.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Inhaled Medications
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Cardiopulmonary Resuscitation III: AED Use
Drug Delivery: Enteral Route

